Forging New Paths: Alfasigma Group and Fangzhou Inc. Chart a Course for Internet Healthcare
SHANGHAI, Nov. 19, 2024 /PRNewswire/ — On November 13th, a high-level delegation from the Alfasigma Group, led by Mr. Andriy Samoylovych, Chief Commercial... Read more.
Hollyland’s Black Friday Event Sets to FREE Shoppers’ Passion for Creativity
SHENZHEN, China, Nov. 19, 2024 /PRNewswire/ — As the holiday season approaches, Hollyland, a leading provider of professional wireless intercom solutions,... Read more.
TransPerfect Media Named Netflix Preferred Fulfillment Partner of the Year 2024 for APAC Region
Award in High-Volume Category Recognizes Perfect On-Time Rate and Project Management Scores NEW YORK, Nov. 19, 2024 /PRNewswire/ — TransPerfect, the world’s... Read more.
TIER IV launches Minibus 2.0 autonomous EV
TOKYO, Nov. 19, 2024 /PRNewswire/ — TIER IV, the pioneering force behind the world’s first open-source software for autonomous driving, is excited to... Read more.
Pinnacle Claims Management, Inc. Provides Notice of Data Incident
LOS ANGELES, Nov. 19, 2024 /PRNewswire/ — Pinnacle Claims Management, Inc. (“PCMI”) experienced a data security incident that may affect the privacy... Read more.
Tokamak Energy raises $125m to commercialize transformative fusion and magnet technologies
PRINCETON, NJ, Nov. 19, 2024 /PRNewswire/ — Tokamak Energy has raised $125 million to accelerate ambitious plans to commercialize fusion energy and grow its... Read more.
Gcore and Ezditek Launch Joint Venture to Accelerate Building, Training, and Deploying AI Solutions in the Kingdom of Saudi Arabia
The joint venture will provide high-performance AI infrastructure optimized for advanced AI workloads while maximizing efficiency, productivity, and sustainability ... Read more.
Plug and Play announces expansion into Seattle along with Partnership with SBI Holdings and SNBL and Future Participation as co-GP in SBI US Gateway Fund
The partnership comprises the establishment of Plug and Play Seattle with SBI Holdings and SNBL as the Founding Anchor partners and Plug and Play’s future... Read more.
Epigenic Therapeutics to Enter Clinical Development of EPI-003: A First-in-Class Epigenetic Inactivator for the Treatment of Chronic Hepatitis B
SHANGHAI, Nov. 19, 2024 /PRNewswire/ — Epigenic Therapeutics, a leading biotechnology company dedicated to developing next-generation gene modulation therapy,... Read more.
Samsung Biologics signs manufacturing deal with European pharmaceutical company
The company will provide manufacturing services through 2031 in deals worth over USD 668 million Samsung Biologics’ cumulative contract value for 2024 surpasses... Read more.